Ligand Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
22 Sep 23 | Buy€222,897 | Todd Davis | Individual | 4,000 | €55.72 | |
16 May 23 | Sell€315,874 | John Kozarich | Individual | 4,444 | €71.08 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 3,848 | 0.0214% |
State or Government | 10,544 | 0.0587% |
General Public | 175,176 | 0.975% |
Individual Insiders | 1,018,934 | 5.67% |
Institutions | 16,749,852 | 93.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,962,314 | €195.0m | 4.27% | no data | |||
1,876,514 | €123.5m | 1.33% | no data | |||
1,343,154 | €88.4m | 0.1% | 0.04% | |||
987,354 | €65.0m | -0.45% | 0.08% | |||
668,284 | €44.0m | 7.22% | no data | |||
661,298 | €43.5m | 7.63% | 0.01% | |||
659,434 | €43.4m | 41% | 0.65% | |||
490,752 | €32.3m | 14.7% | 3.05% | |||
417,695 | €27.5m | 0% | no data | |||
370,815 | €24.4m | 5.16% | no data | |||
325,727 | €21.4m | 59.1% | 0.06% | |||
290,418 | €19.1m | -9.28% | 0.02% | |||
279,784 | €18.4m | 1.37% | 1.19% | |||
229,596 | €15.1m | -0.83% | 0.52% | |||
227,662 | €15.0m | 28.1% | 0.08% | |||
221,927 | €14.6m | 7.52% | 0.73% | |||
219,780 | €14.5m | -0.05% | no data | |||
205,208 | €13.5m | 11.3% | 0.04% | |||
196,498 | €12.9m | 15.6% | 0.02% | |||
194,754 | €12.8m | -5.64% | 0.01% | |||
185,630 | €12.2m | 36.5% | 0.01% | |||
162,187 | €10.7m | 0% | no data | |||
161,480 | €10.6m | 0% | no data | |||
145,094 | €9.6m | -5.83% | no data | |||
143,752 | €9.5m | -2.41% | 0.04% |